SMARCA2-IN-10 (Compound 4) is a highly selective SMARCA2 ATPase domain inhibitor ( IC50 =17.676 μM). SMARCA2-IN-10 induces cell death in SMARCA4-deficient tumors. SMARCA2-IN-10 is promising for research of SMARCA4-mutant non-small cell lung cancer, small cell ovarian carcinoma, and melanoma [1].
References:
[1]. Zhu J, et al. Discovery of Novel Selective Inhibitors of SMARCA2 ATPase Domain by Virtual Screening and Biological Evaluation. ACS Med Chem Lett. 2025 Sep 15;16(10):2032-2040.
References:
[1]. Zhu J, et al. Discovery of Novel Selective Inhibitors of SMARCA2 ATPase Domain by Virtual Screening and Biological Evaluation. ACS Med Chem Lett. 2025 Sep 15;16(10):2032-2040.
















